Intravenous tissue plasminogen activator for ischemic stroke in early pregnancy dosed by actual body weight

INTRODUCTION: Few published reports highlight intravenous tissue plasminogen activator use during the first trimester of pregnancy and provide outcomes for mother and fetus. Little guidance is available regarding body weight dosing of intravenous tissue plasminogen activator during pregnancy. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Peksa, Gary D, Ostrem, Jamie, Davis, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378419/
https://www.ncbi.nlm.nih.gov/pubmed/30800307
http://dx.doi.org/10.1177/2050313X19828247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378419/
https://www.ncbi.nlm.nih.gov/pubmed/30800307
http://dx.doi.org/10.1177/2050313X19828247

Ejemplares similares